RBMY1A1 and liver cancer: Although the wild type female mice are resistant to DEN carcinogenesis due to the protective effect of estrogen-mediated inhibition of IL-6 production by Kupffer cells [32], [33], the results here demonstrate the delivery and activation of a male-specific RBMY gene accelerated liver cancer development even in female transgenic mice.